Biography:
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, He maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology. In 2001, He maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1989 through 1995, He was being a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, Dr Suchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK.
At present, Dr Sergey Suchkov, MD, PhD, is:
● Director for Center of Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Moscow, Russia
● Senior Scientific Advisor of China Hong Kong Innovation International Business Association, Hong Kong
● R&D Director of InMedStar, Russia Member of the:
● Russian Academy of Natural Sciences, Moscow, Russia
● New York Academy of Sciences, USA
● American Chemical Society (ACS), USA
● American Heart Association (AHA), USA
● European Association for Medical Education (AMEE), Dundee, UK
● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU
● ARVO (American Association for Research in Vision and Ophthalmology)
● ISER (International Society for Eye Research)
● Personalized Medicine Coalition (PMC), Washington, DC, USA.


Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health
Title : Natural family planning through the view of personalized and precision reproductive healthcare: An option for clinicians, geneticists and caregivers to realize the potential of genomics-informed care to secure the individualized human biosafety and planetary demographics